Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Voyager Therapeutics, Inc. (VYGR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.82-0.27 (-4.43%)
At close: 04:00PM EDT
5.83 +0.01 (+0.17%)
After hours: 06:36PM EDT
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Revenue
30,928
37,415
171,128
104,391
7,619
Operating Expense
91,088
111,033
143,744
156,070
98,714
Operating Income
-60,160
-73,618
27,384
-51,679
-91,095
Net Non Operating Interest Income Expense
-251
-390
1,659
6,457
3,310
Other Income Expense
577
2,811
7,698
1,625
-683
Pretax Income
-59,834
-71,197
36,741
-43,597
-88,468
Tax Provision
-
-
0
0
-180
Net Income Common Stockholders
-59,834
-71,197
36,741
-43,597
-88,288
Diluted NI Available to Com Stockholders
-59,834
-71,197
36,741
-43,597
-88,288
Basic EPS
-
-1.89
0.99
-1.21
-2.75
Diluted EPS
-
-1.89
0.98
-1.21
-2.75
Basic Average Shares
-
37,669
37,132
35,898
32,066
Diluted Average Shares
-
37,669
37,349
35,898
32,066
Total Operating Income as Reported
-60,160
-73,618
27,384
-51,679
-91,095
Total Expenses
91,088
111,033
143,744
156,070
98,714
Net Income from Continuing & Discontinued Operation
-59,834
-71,197
36,741
-43,597
-88,288
Normalized Income
-59,834
-71,197
36,741
-43,597
-88,288
Interest Income
-
-
1,659
6,457
-
Net Interest Income
-251
-390
1,659
6,457
3,310
EBIT
-60,160
-73,618
27,384
-51,679
-91,095
EBITDA
-53,438
-
-
-
-
Reconciled Depreciation
6,722
5,165
3,817
2,765
2,117
Net Income from Continuing Operation Net Minority Interest
-59,834
-71,197
36,741
-43,597
-88,288
Normalized EBITDA
-53,438
-68,453
31,201
-48,914
-88,978
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
Advertisement
Advertisement